Overview

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers

Status:
COMPLETED
Trial end date:
2024-12-11
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of "BR1019" and co-administration of "BR1019-3" and "BR1019-2" in healthy volunteers
Phase:
PHASE1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd